We use cookies for a better user experience. Click here to know more about it. 

       
  
x

2021-07-28      Pharma & Healthcare

Global Induced Pluripotent Stem Cells (iPSCs) Market Size, Status and Forecast 2021-2027


Induced pluripotent stem cells (also known as iPS cells or iPSCs) are a type of pluripotent stem cell that can be generated directly from adult cells. The opportunities concerning a wide range of diseases including neurodegenerative, metabolic and cardiovascular diseases in a dish for cheaper and faster drug discovery. This may be particularly important in the context of monogenic rare hereditary diseases, where iPSCs can provide an alternative model system to compensate for the lack of a predictive in-vitro human model for drug discovery.

United States is the largest Induced Pluripotent Stem Cells (iPSCs) market with about 43% market share. Europe is follower, accounting for about 33% market share.

The key players are Fujifilm Holding Corporation (CDI), Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma Inc, Fate Therapeutics, Inc, Pluricell Biotech, Cell Inspire Biotechnology, ReproCELL etc. Top 3 companies occupied about 73% market share.

Market Analysis and Insights: Global Induced Pluripotent Stem Cells (iPSCs) Market

The global Induced Pluripotent Stem Cells (iPSCs) market size is projected to reach US$ 203.6 million by 2027, from US$ 90 million in 2020, at a CAGR of 12.3% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Induced Pluripotent Stem Cells (iPSCs) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Induced Pluripotent Stem Cells (iPSCs) market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Induced Pluripotent Stem Cells (iPSCs) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Induced Pluripotent Stem Cells (iPSCs) market.

Induced Pluripotent Stem Cells (iPSCs) Breakdown Data by Type

Human iPSCs

Mouse iPSCs

Human iPSCs had a market share of 89.65% in 2019, followed by Mouse iPSCs.

Induced Pluripotent Stem Cells (iPSCs) Breakdown Data by Application

Academic Research

Drug Development and Discovery

Toxicity Screening

Regenerative Medicine

Others

Academic Research is the largest segment of Induced Pluripotent Stem Cells (iPSCs) application,with a share of 32% in 2019.

Based on regional and country-level analysis, the Induced Pluripotent Stem Cells (iPSCs) market has been segmented as follows:

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Nordic

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia-Pacific

Latin America

Mexico

Brazil

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Induced Pluripotent Stem Cells (iPSCs) market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2016-2021.

The following players are covered in this report:

Fujifilm Holding Corporation (CDI)

Ncardia

Sumitomo Dainippon Pharma

Astellas Pharma Inc

Fate Therapeutics, Inc

Pluricell Biotech

Cell Inspire Biotechnology

ReproCELL

Licenses Type

Only one user can access the report
Multiple users can access the report

Need Help ?

Global Induced Pluripotent Stem Cells iPSCs market

QYR Clients

  • csl
  • croozer
  • crital alert
  • cristal
  • corveneng
  • coperion
  • contijpi medical
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
More Clients...